Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. O-demethyl Tramadol
2. O-demethyltramadol
3. O-demethyltramadol Hydrochloride
4. Tramadol M1 Metabolite
1. O-desmethyl Tramadol
2. (+)-o-desmethyltramadol
3. 80456-81-1
4. Desmetramadol
5. Mono-o-demethyltramadol
6. (+)-o-demethyltramadol
7. Desmetramadol, Cis-(+)-
8. Chembl1400
9. Desmetramadol, R,r-(+)-
10. 2wa8f50c3f
11. 9w28lw2et5
12. 3-((1r,2r)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol
13. Phenol, 3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-, Cis-(+/-)-
14. 144830-14-8
15. O-dsmt
16. Chembl201556
17. Phenol, 3-((1r,2r)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-
18. 3-[(1r,2r)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol
19. Phenol, 3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-, (1r-cis)-
20. Tramadol M1 Metabolite
21. Unii-2wa8f50c3f
22. 3-{(1r,2r)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl}phenol
23. Desmetramadol [inn]
24. Unii-9w28lw2et5
25. Desmetramadol [who-dd]
26. Schembl2517055
27. Chebi:165221
28. Dtxsid401044548
29. Dtxsid901313651
30. 80456-81-1 (free Base)
31. Zinc2509756
32. Bdbm50176258
33. Bdbm50176263
34. Akos030241093
35. Ncgc00165941-01
36. Q63395330
37. Tramadol Hydrochloride Impurity D [ep Impurity]
38. 3-[(1r,2r)-2-[(dimethylamino)methyl]-1-hydroxy-cyclohexyl]phenol
39. (rr,ss)-3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol
40. Rel-3-((1r,2r)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol
41. Phenol, 3-((1r,2r)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-, Rel-
42. Rac-3-((1r,2r)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenolc
| Molecular Weight | 249.35 g/mol |
|---|---|
| Molecular Formula | C15H23NO2 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 249.172878976 g/mol |
| Monoisotopic Mass | 249.172878976 g/mol |
| Topological Polar Surface Area | 43.7 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 269 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ANALYTICAL
ABOUT THIS PAGE
34
PharmaCompass offers a list of Omnitram API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Omnitram manufacturer or Omnitram supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Omnitram manufacturer or Omnitram supplier.
PharmaCompass also assists you with knowing the Omnitram API Price utilized in the formulation of products. Omnitram API Price is not always fixed or binding as the Omnitram Price is obtained through a variety of data sources. The Omnitram Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (+)-O-Desmethyltramadol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (+)-O-Desmethyltramadol, including repackagers and relabelers. The FDA regulates (+)-O-Desmethyltramadol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (+)-O-Desmethyltramadol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A (+)-O-Desmethyltramadol supplier is an individual or a company that provides (+)-O-Desmethyltramadol active pharmaceutical ingredient (API) or (+)-O-Desmethyltramadol finished formulations upon request. The (+)-O-Desmethyltramadol suppliers may include (+)-O-Desmethyltramadol API manufacturers, exporters, distributors and traders.
(+)-O-Desmethyltramadol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (+)-O-Desmethyltramadol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (+)-O-Desmethyltramadol GMP manufacturer or (+)-O-Desmethyltramadol GMP API supplier for your needs.
A (+)-O-Desmethyltramadol CoA (Certificate of Analysis) is a formal document that attests to (+)-O-Desmethyltramadol's compliance with (+)-O-Desmethyltramadol specifications and serves as a tool for batch-level quality control.
(+)-O-Desmethyltramadol CoA mostly includes findings from lab analyses of a specific batch. For each (+)-O-Desmethyltramadol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(+)-O-Desmethyltramadol may be tested according to a variety of international standards, such as European Pharmacopoeia ((+)-O-Desmethyltramadol EP), (+)-O-Desmethyltramadol JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((+)-O-Desmethyltramadol USP).
